Antibacterial efficacy of rifampin loaded solid lipid nanoparticles against Staphylococcus epidermidis biofilm

Microbial Pathogenesis

Volumn 93, Issue , 2016, Pages 137-144

  Fazly Bazzaz, Bibi Sedigheh ^a   Khameneh, Bahman ^a   Zarei, Hamed ^a   Golmohammadzadeh, Shiva ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bacterial biofilm; Bacterial count; Crystal violet; Rifampin; Solid lipid nanoparticles; Staphylococcus epidermidis

Indexed keywords

CRYSTAL VIOLET; RIFAMPICIN; SOLID LIPID NANOPARTICLE; ANTIINFECTIVE AGENT; DRUG CARRIER; LIPID; NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL VIABILITY; BIOFILM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFICACY; DRUG FORMULATION; IN VITRO STUDY; INCUBATION TIME; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMISTRY; DRUG EFFECTS; EVALUATION STUDY; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PARTICLE SIZE; PHYSIOLOGY; PROCEDURES; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; LIPIDS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PARTICLE SIZE; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84958235196     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2015.11.031     Document Type: Article

References (30)

1. Costerton J.W., Cheng K.J., Geesey G.G., Ladd T.I., Nickel J.C., Dasgupta M., Marrie T.J. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 1987, 435-464.
2. Peck Kyong Ran, Kim Shin Woo, Jung S.-I., Kim Yeon-Sook, Oh Won Sup, Lee Ji Young, Jin Joung Hwa, et al. Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. Chemotherapy 2003, 4:189-193.
3. Tamilvanan S., Venkateshan N., Ludwig A. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J. Control Release 2008, 1:2-22.
4. Szczuka E., Kaznowski A. Antimicrobial activity of tigecycline alone or in combination with rifampin against Staphylococcus epidermidis in biofilm. Folia Microbiol. (Praha) 2014, 59:283-288.
5. Molina-Manso D., Del Prado G., Ortiz-Perez A., Manrubia-Cobo M., Gomez-Barrena E., Cordero-Ampuero J., Esteban J. In vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis isolated from prosthetic joint infections. J. Antibiot. (Tokyo) 2012, 10:505-508.
6. Cooper R.A. Inhibition of biofilms by glucose oxidase, lactoperoxidase and guaiacol: the active antibacterial component in an enzyme alginogel. Int. Wound J. 2013, 6:630-637.
7. Kasimanickam R.K., Ranjan A., Asokan G.V., Kasimanickam V.R., Kastelic J.P. Prevention and treatment of biofilms by hybrid- and nanotechnologies. Int. J. Nanomedicine 2013, 2809-2819.
8. Moghadas-Sharif N., Fazly Bazzaz B.S., Khameneh B., Malaekeh-Nikouei B. The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm. Drug Dev. Ind. Pharm. 2015, 41:445-450.
9. Khameneh B., Iranshahy M., Ghandadi M., Ghoochi Atashbeyk D., Fazly Bazzaz B.S., Iranshahi M. Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus. Drug Dev. Ind. Pharm. 2014, 1-6.
10. Atashbeyk D.G., Khameneh B., Tafaghodi M., Fazly Bazzaz B. S.Eradication of methicillin-resistant Staphylococcus aureus infection by nanoliposomes loaded with gentamicin and oleic acid. Pharm. Biol. 2014, 52:1423-1428.
11. Kim H.J., Michael Gias E.L., Jones M.N. The adsorption of cationic liposomes to Staphylococcus aureus biofilms. Colloids Surf. Physicochem. Eng. Asp. 1999, 1-3:561-570.
12. Forier K., Raemdonck K., De Smedt S.C., Demeester J., Coenye T., Braeckmans K. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J. Control. Release 2014, 190:607-623.
13. Mosallaei N., Jaafari M.R., Hanafi-Bojd M.Y., Golmohammadzadeh S., Malaekeh-Nikouei B. Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations. J. Pharm. Sci. 2013, 6:1994-2004.
14. Golmohammadzadeh S., Imani F., Hosseinzadeh H., Jaafari M.R. Preparation, characterization and evaluation of sun protective and moisturizing effects of nanoliposomes containing safranal. Iran. J. Basic Med. Sci. 2011, 6:521-533.
15. Khameneh B., Halimi V., Jaafari M.R., Golmohammadzadeh S. Safranal-loaded solid lipid nanoparticles: evaluation of sunscreen and moisturizing potential for topical applications. Iran. J. Basic Med. Sci. 2015, 18:58-63.
16. Tong Chen, Rong Wang, Li Qun Xu, Koon Gee Neoh, Kang En-Tang Carboxymethyl chitosan-functionalized magnetic nanoparticles for disruption of biofilms of Staphylococcus aureus and Escherichia coli. Ind. Eng. Chem. Res. 2012, 40:13164-13172.
17. Mehnert W., Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 2001, 2-3:165-196.
18. Tiyaboonchai W., Tungpradit W., Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 2007, 1-2:299-306.
19. Yan F., Zhang C., Zheng Y., Mei L., Tang L., Song C., Sun H., Huang L. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine 2010, 1:170-178.
20. Zhen Li, Li Yu, Liqiang Zheng, Fei Geng Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method. J. Therm. Anal. Calorim. 2010, 2:689-693.
21. Nightingale S.D., Saletan S.L., Swenson C.E., Lawrence A.J., Watson D.A., Pilkiewicz F.G., Silverman E.G., Cal S.X. Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients. Antimicrob. Agents Chemother. 1993, 9:1869-1872.
22. Fontana G., Schillaci D. Solid lipid nanoparticles containing vancomycin: preparation, characterization and in vitro anti-Staphylococcus aureus biofilms activity. Gazz. Med. Ital. Arch. Sci. Med. 2009, 2:89-93.
23. Sanderson N.M., Jones M.N. Encapsulation of vancomycin and gentamicin within cationic liposomes for inhibition of growth of Staphylococcus epidermidis. J. Drug Target 1996, 3:181-189.
24. Robinson Anne M., Mark Bannister, Creeth Jonathan E., Jones Malcolm N. The interaction of phospholipid liposomes with mixed bacterial biofilms and their use in the delivery of bactericide. Colloids Surf. Physicochem. Eng. Asp. 2001, 1:43-53.
25. Zhou T.H., Su M., Shang B.C., Ma T., Xu G.L., Li H.L., Chen Q.H., et al. Nano-hydroxyapatite/beta-tricalcium phosphate ceramics scaffolds loaded with cationic liposomal ceftazidime: preparation, release characteristics in vitro and inhibition to Staphylococcus aureus biofilms. Drug Dev. Ind. Pharm. 2012, 11:1298-1304.
26. Jones Malcolm N., Hill Kate J., Michael Kaszuba, Creeth Jonathan E. Antibacterial reactive liposomes encapsulating coupled enzyme systems. Int. J. Pharm. 1998, 1-2:107-117.
27. Kim H.J., Jones M.N. The delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomes. J. Liposome Res. 2004, 3-4:123-139.
28. ®) for cutaneous drug delivery: structure, protection and skin effects. J. Biomed. Nanotechnol. 2007, 3:317-331.
29. Jones M.N., Song Y.H., Kaszuba M., Reboiras M.D. The interaction of phospholipid liposomes with bacteria and their use in the delivery of bactericides. J. Drug Target 1997, 1:25-34.
30. Kim Hee-Jeong, Michael Gias Edna L., Jones Malcolm N. The adsorption of cationic liposomes to Staphylococcus aureus biofilms. Colloids Surf. Physicochem. Eng. Asp. 1999, 1:561-570.